FdaApprovalPulse: Other drug supplement
12 fdaApprovalPulse: Other drug supplement are listed from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration), dated 2026-05-12 to 2026-09-29; the most frequent is AMGEN INC with 4. Data last updated 2026-11-03; each record links to its official source and a full report.
Data as of · Compiled by Zalwin from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)
Includes: Sponsor, Product, Approval, Decided, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe
12 records from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration), dated 2026-05-12 to 2026-09-29. Most frequent: AMGEN INC (4). Each record links to a full report and the official source.
Last updated 2026-11-03. Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration).
Get new FdaApprovalPulse records by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
- AMGEN INC (4)
- CELLTRION INC (2)
- TEVA PHARMACEUTICALS, INC. (1)
- PFIZER INC (1)
- EMERGE BIOSCIENCE PTE LTD (1)
How do I get new fdaApprovalPulse: Other drug supplement by email?
Search, filter and export these records, or get alerts when new ones appear.
What are the top fdaApprovalPulse: Other drug supplement right now?
| Record | Product | Approval | Decided |
|---|---|---|---|
| AMGEN INC | RIABNI | Other drug supplement | 2026-09-29 |
| TEVA PHARMACEUTICALS, INC. | PONLIMSI | Other drug supplement | 2026-09-29 |
| CELLTRION INC | AVTOZMA | Other drug supplement | 2026-09-29 |
| PFIZER INC | RUXIENCE | Other drug supplement | 2026-09-28 |
| EMERGE BIOSCIENCE PTE LTD | YUSIMRY | Other drug supplement | 2026-09-25 |
| GILEAD SCIENCES INC | BIXLENVO SUNLENCA STARTER PACK (COPACKAGED) | Other drug supplement | 2026-08-27 |
| AMGEN INC | BKEMV | Other drug supplement | 2026-06-29 |
| SAMSUNG BIOEPIS CO LTD | EPYSQLI | Other drug supplement | 2026-06-29 |
| CELLTRION INC | TRUXIMA | Other drug supplement | 2026-06-29 |
| ACCORD BIOPHARMA INC. | IMULDOSA | Other drug supplement | 2026-06-05 |
| AMGEN INC | WEZLANA | Other drug supplement | 2026-05-12 |
| AMGEN INC | WEZLANA | Other drug supplement | 2026-05-12 |
Which related categories and locations should I check?
Browse by approval type
Drug labeling or REMS supplement (1174) PMA supplement (device change) (367) Generic drug approval (ANDA) (194) Drug efficacy supplement (new indication or use) (76) Drug manufacturing (CMC) supplement (55) New drug application (NDA) (40) PMA original approval (new class III device) (24) Biologic license (BLA) (17)
Browse by sponsor state (devices)
California (110) Minnesota (61) Massachusetts (37) Oregon (20) Arizona (18) Texas (18) Illinois (9) Maryland (9) Tennessee (8) Pennsylvania (7) Florida (6) Washington (6) Missouri (5) Wisconsin (5) Colorado (4) Connecticut (4) Georgia (4) Indiana (4) New Jersey (4) New York (4) North Carolina (3) Ohio (3)
Frequently asked questions
How many fdaApprovalPulse: Other drug supplement are listed?
12 records from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration), last refreshed automatically. The most recent is dated 2026-09-29.
Can I get alerts for Other drug supplement?
Yes. FdaApprovalPulse can email you new records matching this filter; plans are listed on the FdaApprovalPulse page.
Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration). Informational only. RSS feed of new records